Scotts Miracle-Gro (SMG) EBITDA Margin (2009 - 2026)

Scotts Miracle-Gro has disclosed EBITDA Margin across 18 years of filings, most recently posting 27.53% for Q1 2026.

• EBITDA Margin for Q1 2026 came in at 27.53%, up 237.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 13.13% (up 459.0% YoY), and the FY2025 annual result was 10.51%, up 463.0% from the prior year.
• EBITDA Margin came in at 27.53% for Q1 2026 at Scotts Miracle-Gro, up from 6.15% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 27.53% in Q1 2026 to a low of 111.11% in Q3 2023.
• The 5-year median for EBITDA Margin is 6.2% (2022), against an average of 10.58%.
• Across the five-year window, EBITDA Margin slumped 6619 bps in 2022 and soared 5900 bps in 2024, its largest moves.
• Scotts Miracle-Gro's EBITDA Margin stood at 7.94% in 2022, then slumped by 45 bps to 11.53% in 2023, then retreated by 8 bps to 12.49% in 2024, then jumped by 51 bps to 6.15% in 2025, then jumped by 548 bps to 27.53% in 2026.
• The last three EBITDA Margin figures came in at 27.53% (Q1 2026), 6.15% (Q4 2025), and 38.76% (Q3 2025), per Business Quant data.